In recent years, the landscape of non-hormonal drugs for VMS has expanded significantly, offering alternatives for women who are contraindicated or prefer not to use hormone therapy (HT). This module focuses on new neurokinin receptor antagonists authorized by Health Canada for treatment of VMS. Neurokinin is a small signalling molecule in the brain that helps to regulate temperature, mood, pain, and stress responses. Neurokinin receptor antagonists are a class of drugs that block the action of neurokinins.
Authorized Non-Hormonal VMS Therapies
CAN-eng
$0
gratuit
Non accrédité
5 min
Santé des femmes
0 Crédits
Description du cours
Détails du cours
Date d'expiration : 2026-10-04
Métiers: Médecin
Faculté
Accréditation
Objectif(s) d'apprentissage
After viewing this microlearning, participants will be better able to:
- Reconnaître the most recently authorized non-hormonal therapy for VMS in Canada